Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Connecting Families to Overcome Ovarian Cancer [NA]
Emory University-led trial evaluating a family-centered approach to ovarian cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer [Phase 1]
A Phase 1 crossover bioequivalence study comparing Olaparib 150 mg tablets from Lek Pharmaceuticals with Lynparza 150 mg tablets in BRCA-mut…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors [Phase 1, Phase 2]
Phase 1/2 trial of BNT141 in CLDN18.2-positive gastric, pancreatic, ovarian, and biliary tract cancers. The study was terminated and results…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients
An exploratory study in Chinese ovarian cancer patients to examine whether the homologous recombination deficiency (HRD) score correlates wi…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating BMX-001 combined with paclitaxel in adults with advanced, recurrent, metastatic ovarian or endom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: The Role of CircDENND4C in Epithelial Ovarian Cancer
A clinical trial by Assiut University is investigating CircDENND4C in epithelial ovarian cancer and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer
An Exscientia AI-led study evaluating whether ex vivo drug response (EVDR) correlates with clinical outcomes in epithelial ovarian cancer ha…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Clinical Study of 18F-FAPI-RGD in Ovarian Cancer
This document reports that an observational clinical study evaluating the imaging tracer 18F-FAPI-RGD in ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Efficacy of Biofeedback-Based Serious Game for Pain Alleviation in Middle-Aged and Older Ovarian Cancer Patients: A Randomized Controlled Trial [NA]
A completed randomized controlled trial evaluated the efficacy of a biofeedback-based serious game for pain relief in middle-aged and older …
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 bioequivalence study comparing the proposed talazoparib capsule formulation to the current formulation, plus a food-effect assessmen…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer
Completed trial assessing outcomes of olaparib maintenance monotherapy in newly diagnosed BRCA wild-type ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) [Phase 2]
Phase 2 Imperial College London study evaluating dual mTORC1/2 inhibition in advanced or recurrent epithelial ovarian, fallopian tube, or pr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: BR55 in Characterization of Ovarian Lesions [Phase 2]
Phase 2 trial evaluating the BR55 ultrasound contrast agent for characterizing ovarian lesions in ovarian cancer was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. [Phase 1]
Phase I study of Cantrixil in ovarian, fallopian tube, and primary peritoneal cancers has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer [Phase 1]
This Phase 1 trial evaluated the combination of fostamatinib and paclitaxel in ovarian cancer; the study completed and results were posted o…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]
Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Connecting Audio and Radio Sensing Systems to Improve Care at Home
Completed study evaluating an audio and radio sensing system to support at-home care for cancer patients. The trial enrolled participants wi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating NY-ESO-1 TCR-engineered T cells with hematopoietic stem cells after melphalan conditioning in recurrent or refrac…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Adebrelimab combined with non-platinum chemotherapy and Fuzuloparib for recurrent platinum-resistant ovarian cancer…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors [Phase 1, Phase 2]
A Phase 1b/2a trial evaluating ENB003 in combination with pembrolizumab for various solid tumors, including melanoma, ovarian cancer, pancre…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
This Clinical Trial Update documents the establishment and standardization of a platform for in-depth tumor profiling (TUPRO-Gyn) in patient…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer [Phase 1]
A Phase 1 study examining the combination of pressurized intraperitoneal aerosol chemotherapy with systemic chemotherapy in women with advan…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Gynecological Cancer Associated Thrombosis (GynCAT) Study
The Gynecological Cancer Associated Thrombosis (GynCAT) study is currently recruiting to investigate cancer-associated thrombosis and venous…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Asian Multicenter Prospective Study of ctDNA Sequencing
Clinical trial update on an Asian multicenter prospective study evaluating circulating tumor DNA sequencing across multiple cancers, sponsor…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating platinum-based chemotherapy with Atezolizumab and Niraparib in patients with recurrent ovarian cancer has complet…